Bee product mouthwash may prevent painful mouth sores in ICU patients
NCT ID NCT07426198
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding a propolis mouth rinse to standard oral care could prevent or reduce mouth sores in 60 COPD patients in the intensive care unit. Half the patients received propolis care for 15 days, while the other half got standard care only. Researchers checked their mouths on days 1, 7, and 15 to see how the sores developed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- propolis
- What this could lead to
- If it works, this could offer a simple, natural mouth rinse to help prevent painful mouth sores in ICU patients with COPD.
- What could go wrong
- This is a small, completed trial with only 60 patients, so results may not apply to everyone. Propolis can cause allergic reactions in people allergic to bees.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 18 years or older, * diagnosed with COPD, * no oral mucositis at the start of the study, * no known allergy to bees or bee products, * able to speak and understand Turkish and communicate effectively, * conscious, * without any psychiatric illness, * without any mental or physical disability that would prevent them from answering questions, * individuals who volunteered to participate in the study were included in the study. Exclusion Criteria: * individuals with a cancer diagnosis, * individuals receiving immunosuppressive therapy, * individuals receiving mechanical ventilation support, * individuals with altered consciousness or acute confusion, * individuals who did not volunteer to participate in the study were excluded from the research.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Oral mucositis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erciyes University
Talas, Kayseri, 38039, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mouth device aims to keep Sore-Relief rinses where They're needed
- Can toothbrushing and rinses stop painful mouth sores in child transplant patients?
- Can a probiotic shield cancer patients from radiation mouth sores?
- Amazon tree resin mouthwash tested against painful transplant side effect
- Aloe vera mouthwash tested against chemotherapy mouth sores
- Olive oil and xylitol mouth rinse may shield cancer patients from painful mouth sores